Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

PT-141 Doses Per Vial: Standard vs Custom Comparison

10mg 2mL 5mg/mL 1mg 0.2mL 10 28 days refrigerated Standard protocol. Balances dose count, injection volume, and stability window for most individual use cases 1.5mg 0.3mL 6–7 Higher-dose protocol. Fewer total administrations but potentially stronger per-dose e

This comparison does not assign a generated winner or score.

  • 10mg
  • 2mL
  • 5mg/mL
  • 1mg
  • 0.2mL
  • 10
  • 28 days refrigerated
  • Standard protocol. Balances dose count, injection volume, and stability window for most individual use cases
  • 1.5mg
  • 0.3mL
  • 6–7
  • Higher-dose protocol. Fewer total administrations but potentially stronger per-dose effect; fits well within stability window
  • 1mL
  • 10mg/mL
  • 0.1mL
  • High-concentration protocol. Same dose count as 2mL reconstitution but smaller injection volumes; may increase injection site irritation
  • 0.5mg
  • 20
  • Low-dose protocol. Maximum dose count but impractical for most users due to 28-day window; requires dosing every 1–1.5 days
  • 20mg
  • Larger vial size. Doubles dose count but requires faster use rate or multi-subject protocols to stay within stability window
  • The comparison shows that vial size and reconstitution volume are the two variables you control before mixing. And they determine whether your dose count aligns with your protocol timeline. A 10mg vial at 1mg per dose is the sweet spot for most single-user research protocols: 10 administrations over 20–30 days fits comfortably inside the 28-day refrigerated stability limit, and 0.2mL injection volumes are easy to measure accurately with standard insulin syringes.
More references

Related material